Fed Regist. 2011 Jul 21;76(140):43582-5.
The Food and Drug Administration (FDA) is classifying the electrocardiograph electrode, intended to acquire and transmit the electrical signal at the body surface to a processor that produces an electrocardiogram (ECG) or vectorcardiogram, into class II (special controls). FDA is also exempting this device from the premarket notification requirement.
美国食品药品监督管理局(FDA)正在将旨在获取体表电信号并将其传输至生成心电图(ECG)或向量心电图的处理器的心电图电极归类为II类(特殊控制)。FDA还免除了该设备的上市前通知要求。